"Dana–Farber Cancer Institute – Chestnut Hill is a multi-disciplinary cancer treatment center in Chestnut Hill, Massachusetts. Specific services are open Monday through Friday, at the following times: Exam: 7:30 a.m. – 6:00 p.m. Infusion: 7 a.m. – 8:30 p.m. Lab Services: 6:30 a.m. – 4:30 p.m."

During the past decade, Dana-Farber Cancer Institute - Chestnut Hill conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dana-Farber Cancer Institute - Chestnut Hill" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dana-Farber Cancer Institute - Chestnut Hill" are "Locally Advanced Bladder Urothelial Carcinoma" (2 trials), "Locally Advanced Ureter Urothelial Carcinoma" (2 trials), "Locally Advanced Urothelial Carcinoma" (2 trials), "ALK Gene Rearrangement" (1 trials) and "ALK Gene Translocation" (1 trials). Many other conditions were trialed in "Dana-Farber Cancer Institute - Chestnut Hill" in a lesser frequency.

Most popular intervention types in "Dana-Farber Cancer Institute - Chestnut Hill" are "Drug" (7 trials), "Other" (4 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (3 trials), "Biospecimen Collection" (2 trials), "Clinical Observation" (2 trials), "Computed Tomography" (2 trials) and "Magnetic Resonance Imaging" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dana-Farber Cancer Institute - Chestnut Hill" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Dana-Farber Cancer Institute - Chestnut Hill". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dana-Farber Cancer Institute - Chestnut Hill, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dana-Farber Cancer Institute - Chestnut Hill, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".